{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T17:11:44Z","timestamp":1795194704662,"version":"4.10.3"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,20]]},"DOI":"10.7759\/cureus.34003","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T16:14:31Z","timestamp":1674231271000},"source":"Crossref","is-referenced-by-count":13,"title":["Pediatric Sickle Cell Disease and Stroke: A Literature Review"],"prefix":"10.7759","author":[{"given":"Taral","family":"Parikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Goti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanica","family":"Yashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen Prasad","family":"Gopalakrishnan Ravikumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendrasinh","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilesh","family":"Dankhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vimal","family":"Satodiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1104","article-title":"Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis","volume":"1","author":"Piel FB","year":"2010","unstructured":"Piel FB, Patil AP, Howes RE, et al.. Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat Commun. 2010, 1:104. 10.1038\/ncomms1104","journal-title":"Nat Commun"},{"key":"ref2","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors","volume":"91","author":"Ohene-Frempong K","year":"1998","unstructured":"Ohene-Frempong K, Weiner SJ, Sleeper LA, et al.. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998, 91:288-94.","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/BF01956144","article-title":"Cerebrovascular accidents in sickle cell disease. Risk factors and blood transfusion influence. French Study Group on Sickle Cell Disease","volume":"152","author":"de Montalembert M","year":"1993","unstructured":"de Montalembert M, Beauvais P, Bachir D, Galacteros F, Girot R. Cerebrovascular accidents in sickle cell disease. Risk factors and blood transfusion influence. French Study Group on Sickle Cell Disease. Eur J Pediatr. 1993, 152:201-4. 10.1007\/BF01956144","journal-title":"Eur J Pediatr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-7687.2006.00507.x","article-title":"Hypoxic adaptation during development: relation to pattern of neurological presentation and cognitive disability","volume":"9","author":"Kirkham FJ","year":"2006","unstructured":"Kirkham FJ, Datta AK. Hypoxic adaptation during development: relation to pattern of neurological presentation and cognitive disability. Dev Sci. 2006, 9:411-27. 10.1111\/j.1467-7687.2006.00507.x","journal-title":"Dev Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.562","article-title":"Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia","volume":"303","author":"Vichinsky EP","year":"2010","unstructured":"Vichinsky EP, Neumayr LD, Gold JI, et al.. Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia. JAMA. 2010, 303:1823-31. 10.1001\/jama.2010.562","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08344.x","article-title":"Seizures in the Jamaica cohort study of sickle cell disease","volume":"151","author":"Ali SB","year":"2010","unstructured":"Ali SB, Reid M, Fraser R, MooSang M, Ali A. Seizures in the Jamaica cohort study of sickle cell disease. Br J Haematol. 2010, 151:265-72. 10.1111\/j.1365-2141.2010.08344.x","journal-title":"Br J Haematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200006223422502","article-title":"Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group","volume":"342","author":"Vichinsky EP","year":"2000","unstructured":"Vichinsky EP, Neumayr LD, Earles AN, et al.. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med. 2000, 342:1855-65. 10.1056\/NEJM200006223422502","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-272682","article-title":"Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia","volume":"119","author":"DeBaun MR","year":"2012","unstructured":"DeBaun MR, Armstrong FD, McKinstry RC, Ware RE, Vichinsky E, Kirkham FJ. Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia. Blood. 2012, 119:4587-96. 10.1182\/blood-2011-02-272682","journal-title":"Blood"},{"key":"ref9","article-title":"Stroke in children in Yaounde, Cameroon","volume":"31","author":"Obama MT","year":"1994","unstructured":"Obama MT, Dongmo L, Nkemayim C, Mbede J, Hagbe P. Stroke in children in Yaounde, Cameroon. Indian Pediatr. 1994, 31:791-5.","journal-title":"Indian Pediatr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24986","article-title":"The clinical epidemiology of sickle cell anemia in Africa","volume":"93","author":"Macharia AW","year":"2018","unstructured":"Macharia AW, Mochamah G, Uyoga S, et al.. The clinical epidemiology of sickle cell anemia in Africa. Am J Hematol. 2018, 93:363-70. 10.1002\/ajh.24986","journal-title":"Am J Hematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.51.1.169","article-title":"Stroke in children and sickle-cell disease. Baltimore-Washington Cooperative Young Stroke Study","volume":"51","author":"Earley CJ","year":"1998","unstructured":"Earley CJ, Kittner SJ, Feeser BR, et al.. Stroke in children and sickle-cell disease. Baltimore-Washington Cooperative Young Stroke Study. Neurology. 1998, 51:169-76. 10.1212\/wnl.51.1.169","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21476","article-title":"The excess burden of stroke in hospitalized adults with sickle cell disease","volume":"84","author":"Strouse JJ","year":"2009","unstructured":"Strouse JJ, Jordan LC, Lanzkron S, Casella JF. The excess burden of stroke in hospitalized adults with sickle cell disease. Am J Hematol. 2009, 84:548-52. 10.1002\/ajh.21476","journal-title":"Am J Hematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1586\/ehm.11.61","article-title":"The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease","volume":"4","author":"Strouse JJ","year":"2011","unstructured":"Strouse JJ, Lanzkron S, Urrutia V. The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease. Expert Rev Hematol. 2011, 4:597-606. 10.1586\/ehm.11.61","journal-title":"Expert Rev Hematol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(78)90772-6","article-title":"The natural history of stroke in sickle cell disease","volume":"65","author":"Powars D","year":"1978","unstructured":"Powars D, Wilson B, Imbus C, Pegelow C, Allen J. The natural history of stroke in sickle cell disease. Am J Med. 1978, 65:461-71. 10.1016\/0002-9343(78)90772-6","journal-title":"Am J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)80897-2","article-title":"Stroke in a cohort of patients with homozygous sickle cell disease","volume":"120","author":"Balkaran B","year":"1992","unstructured":"Balkaran B, Char G, Morris JS, Serjeant BE, Serjeant GR. Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr. 1992, 120:360-6. 10.1016\/S0022-3476(05)80897-2","journal-title":"J Pediatr"},{"key":"ref16","article-title":"Stroke in Nigerian children with sickle cell disease","volume":"34","author":"Fatunde OJ","year":"2005","unstructured":"Fatunde OJ, Adamson FG, Ogunseyinde O, Sodeinde O, Familusi JB. Stroke in Nigerian children with sickle cell disease. Afr J Med Med Sci. 2005, 34:157-60.","journal-title":"Afr J Med Med Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2006.07.003","article-title":"The epidemiology of stroke in sickle cell patients in Yaounde, Cameroon","volume":"250","author":"Njamnshi AK","year":"2006","unstructured":"Njamnshi AK, Mbong EN, Wonkam A, et al.. The epidemiology of stroke in sickle cell patients in Yaounde, Cameroon. J Neurol Sci. 2006, 250:79-84. 10.1016\/j.jns.2006.07.003","journal-title":"J Neurol Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10184232","article-title":"Epidemiology of stroke in sickle cell disease","volume":"10","author":"Kirkham FJ","year":"2021","unstructured":"Kirkham FJ, Lagunju IA. Epidemiology of stroke in sickle cell disease. J Clin Med. 2021, 10:4232. 10.3390\/jcm10184232","journal-title":"J Clin Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/10245332.2015.1101976","article-title":"Complications of sickle cell anaemia in children in Northwestern Tanzania","volume":"21","author":"Saidi H","year":"2016","unstructured":"Saidi H, Smart LR, Kamugisha E, Ambrose EE, Soka D, Peck RN, Makani J. Complications of sickle cell anaemia in children in Northwestern Tanzania. Hematology. 2016, 21:248-56. 10.1080\/10245332.2015.1101976","journal-title":"Hematology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-019-1758-2","article-title":"Burden of neurological and neurocognitive impairment in pediatric sickle cell anemia in Uganda (BRAIN SAFE): a cross-sectional study","volume":"19","author":"Green NS","year":"2019","unstructured":"Green NS, Munube D, Bangirana P, et al.. Burden of neurological and neurocognitive impairment in pediatric sickle cell anemia in Uganda (BRAIN SAFE): a cross-sectional study. BMC Pediatr. 2019, 19:381. 10.1186\/s12887-019-1758-2","journal-title":"BMC Pediatr"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2014.08.001","article-title":"Association of alpha-thalassemia, TNF-alpha (-308G>A) and VCAM-1 (c.1238G>C) gene polymorphisms with cerebrovascular disease in a newborn cohort of 411 children with sickle cell anemia","volume":"54","author":"Belis\u00e1rio AR","year":"2015","unstructured":"Belis\u00e1rio AR, Nogueira FL, Rodrigues RS, et al.. Association of alpha-thalassemia, TNF-alpha (-308G&gt;A) and VCAM-1 (c.1238G&gt;C) gene polymorphisms with cerebrovascular disease in a newborn cohort of 411 children with sickle cell anemia. Blood Cells Mol Dis. 2015, 54:44-50. 10.1016\/j.bcmd.2014.08.001","journal-title":"Blood Cells Mol Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1993.tb00613.x","article-title":"Epidemiological and clinical study of sickle cell disease in France, French Guiana and Algeria","volume":"51","author":"de Montalembert M","year":"1993","unstructured":"de Montalembert M, Guilloud-Bataille M, Feingold J, Girot R. Epidemiological and clinical study of sickle cell disease in France, French Guiana and Algeria. Eur J Haematol. 1993, 51:136-40. 10.1111\/j.1600-0609.1993.tb00613.x","journal-title":"Eur J Haematol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28130","article-title":"Sickle cell disease in Germany: results from a national registry","volume":"67","author":"Kunz JB","year":"2020","unstructured":"Kunz JB, Lobitz S, Grosse R, et al.. Sickle cell disease in Germany: results from a national registry. Pediatr Blood Cancer. 2020, 67:e28130. 10.1002\/pbc.28130","journal-title":"Pediatr Blood Cancer"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/s1695-4033(03)78011-4","article-title":"Sickle cell anemia: experience in a center","volume":"58","author":"G\u00f3mez-Chiari M","year":"2003","unstructured":"G\u00f3mez-Chiari M. Sickle cell anemia: experience in a center. Anales de Pediatr\u00eda. 2003, 58:95-9. 10.1016\/s1695-4033(03)78011-4","journal-title":"Anales de Pediatr\u00eda"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26322","article-title":"National registry of hemoglobinopathies in Spain (REPHem)","volume":"64","author":"Cela E","year":"2017","unstructured":"Cela E, Bell\u00f3n JM, de la Cruz M, et al.. National registry of hemoglobinopathies in Spain (REPHem). Pediatr Blood Cancer. 2017, 64:e26322. 10.1002\/pbc.26322","journal-title":"Pediatr Blood Cancer"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2021.102567","article-title":"Co-morbidities and mortality in patients with sickle cell disease in England: a 10-year cohort analysis using hospital episodes statistics (HES) data","volume":"89","author":"Piel FB","year":"2021","unstructured":"Piel FB, Jobanputra M, Gallagher M, Weber J, Laird SG, McGahan M. Co-morbidities and mortality in patients with sickle cell disease in England: a 10-year cohort analysis using hospital episodes statistics (HES) data. Blood Cells Mol Dis. 2021, 89:102567. 10.1016\/j.bcmd.2021.102567","journal-title":"Blood Cells Mol Dis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-012-1204-9","article-title":"Adverse neurological outcomes in Nigerian children with sickle cell disease","volume":"96","author":"Lagunju IA","year":"2012","unstructured":"Lagunju IA, Brown BJ. Adverse neurological outcomes in Nigerian children with sickle cell disease. Int J Hematol. 2012, 96:710-8. 10.1007\/s12185-012-1204-9","journal-title":"Int J Hematol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S0027-9684(15)31271-2","article-title":"Neurological complications of sickle cell anemia in Nigerian Africans\u2014a case-control study","volume":"100","author":"Kehinde MO","year":"2008","unstructured":"Kehinde MO, Temiye EO, Danesi MA. Neurological complications of sickle cell anemia in Nigerian Africans\u2014a case-control study. J Natl Med Assoc. 2008, 100:394-400. 10.1016\/S0027-9684(15)31271-2","journal-title":"J Natl Med Assoc"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2020.1714113","article-title":"Distribution of sickle cell disease and assessment of risk factors based on transcranial Doppler values in the Gulf region","volume":"25","author":"Wali Y","year":"2020","unstructured":"Wali Y, Kini V, Yassin MA. Distribution of sickle cell disease and assessment of risk factors based on transcranial Doppler values in the Gulf region. Hematology. 2020, 25:55-62. 10.1080\/16078454.2020.1714113","journal-title":"Hematology"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1080\/03630269.2019.1610427","article-title":"The sub-phenotypes of sickle cell disease in Kuwait","volume":"43","author":"Adekile AD","year":"2019","unstructured":"Adekile AD, Al-Sherida S, Marouf R, Mustafa N, Thomas D. The sub-phenotypes of sickle cell disease in Kuwait. Hemoglobin. 2019, 43:83-7. 10.1080\/03630269.2019.1610427","journal-title":"Hemoglobin"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1089\/gtmb.2018.0058","article-title":"Utilizing whole-exome sequencing to characterize the phenotypic variability of sickle cell disease","volume":"22","author":"Alsultan A","year":"2018","unstructured":"Alsultan A, Al-Suliman AM, Aleem A, AlGahtani FH, Alfadhel M. Utilizing whole-exome sequencing to characterize the phenotypic variability of sickle cell disease. Genet Test Mol Biomarkers. 2018, 22:561-7. 10.1089\/gtmb.2018.0058","journal-title":"Genet Test Mol Biomarkers"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12650","article-title":"Sickle cell disease in Saudi Arabia: the phenotype in adults with the Arab-Indian haplotype is not benign","volume":"164","author":"Alsultan A","year":"2014","unstructured":"Alsultan A, Alabdulaali MK, Griffin PJ, et al.. Sickle cell disease in Saudi Arabia: the phenotype in adults with the Arab-Indian haplotype is not benign. Br J Haematol. 2014, 164:597-604. 10.1111\/bjh.12650","journal-title":"Br J Haematol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e3182422844","article-title":"Sickle cell disease subphenotypes in patients from Southwestern Province of Saudi Arabia","volume":"34","author":"Alsultan A","year":"2012","unstructured":"Alsultan A, Aleem A, Ghabbour H, et al.. Sickle cell disease subphenotypes in patients from Southwestern Province of Saudi Arabia. J Pediatr Hematol Oncol. 2012, 34:79-84. 10.1097\/MPH.0b013e3182422844","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12440","article-title":"Risk factors and complications among pediatric patients with sickle cell anemia: a single tertiary center retrospective study","volume":"13","author":"Alzahrani F","year":"2021","unstructured":"Alzahrani F, Fallatah AM, Al-Haddad FM, Khayyat ST, AlMehmadi WM, AlQahtani BG, Alamri RS. Risk factors and complications among pediatric patients with sickle cell anemia: a single tertiary center retrospective study. Cureus. 2021, 13:e12440. 10.7759\/cureus.12440","journal-title":"Cureus"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2013-304243","article-title":"Stroke in paediatric pneumococcal meningitis: a cross-sectional population-based study","volume":"98","author":"Pryde K","year":"2013","unstructured":"Pryde K, Walker WT, Hollingsworth C, et al.. Stroke in paediatric pneumococcal meningitis: a cross-sectional population-based study. Arch Dis Child. 2013, 98:647-9. 10.1136\/archdischild-2013-304243","journal-title":"Arch Dis Child"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-233700","article-title":"Improved survival of children and adolescents with sickle cell disease","volume":"115","author":"Quinn CT","year":"2010","unstructured":"Quinn CT, Rogers ZR, McCavit TL, Buchanan GR. Improved survival of children and adolescents with sickle cell disease. Blood. 2010, 115:3447-52. 10.1182\/blood-2009-07-233700","journal-title":"Blood"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10937","article-title":"Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London","volume":"92","author":"Telfer P","year":"2007","unstructured":"Telfer P, Coen P, Chakravorty S, et al.. Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London. Haematologica. 2007, 92:905-12. 10.3324\/haematol.10937","journal-title":"Haematologica"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198606193142501","article-title":"Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial","volume":"314","author":"Gaston MH","year":"1986","unstructured":"Gaston MH, Verter JI, Woods G, et al.. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med. 1986, 314:1593-9. 10.1056\/NEJM198606193142501","journal-title":"N Engl J Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199202273260905","article-title":"The use of transcranial ultrasonography to predict stroke in sickle cell disease","volume":"326","author":"Adams R","year":"1992","unstructured":"Adams R, McKie V, Nichols F, et al.. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med. 1992, 326:605-10. 10.1056\/NEJM199202273260905","journal-title":"N Engl J Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410420505","article-title":"Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler","volume":"42","author":"Adams RJ","year":"1997","unstructured":"Adams RJ, McKie VC, Carl EM, et al.. Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol. 1997, 42:699-704. 10.1002\/ana.410420505","journal-title":"Ann Neurol"},{"key":"ref41","doi-asserted-by":"crossref","DOI":"10.1136\/archdischild-2012-301885.111","article-title":"Prospective measurement of stroke incidence in childhood sickle cell disease","volume":"97","author":"Lagunju I","year":"2012","unstructured":"Lagunju I, Sodeinde O. Prospective measurement of stroke incidence in childhood sickle cell disease. Arch Dis Childh. 2012, 97:A45.","journal-title":"Arch Dis Childh"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000000633","article-title":"Transcranial Doppler screening in a regional care network for sickle cell disease in the United Kingdom","volume":"38","author":"Telfer P","year":"2016","unstructured":"Telfer P, Dwan K, Simmons A, et al.. Transcranial Doppler screening in a regional care network for sickle cell disease in the United Kingdom. J Pediatr Hematol Oncol. 2016, 38:517-24. 10.1097\/MPH.0000000000000633","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3233\/JPN-2010-0431","article-title":"Childhood stroke in sickle cell disease in Nigeria","volume":"9","author":"Lagunju IA","year":"2011","unstructured":"Lagunju IA, Brown BJ, Famosaya AA. Childhood stroke in sickle cell disease in Nigeria. J Pediatric Neurol. 2011, 9:49-53. 10.3233\/JPN-2010-0431","journal-title":"J Pediatric Neurol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25900","article-title":"Moderate fixed-dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: final results of the SPIN trial","volume":"95","author":"Galadanci NA","year":"2020","unstructured":"Galadanci NA, Abdullahi SU, Ali Abubakar S, et al.. Moderate fixed-dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: final results of the SPIN trial. Am J Hematol. 2020, 95:E247-50. 10.1002\/ajh.25900","journal-title":"Am J Hematol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001142","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults","volume":"4","author":"DeBaun MR","year":"2020","unstructured":"DeBaun MR, Jordan LC, King AA, et al.. American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults. Blood Adv. 2020, 4:1554-88. 10.1182\/bloodadvances.2019001142","journal-title":"Blood Adv"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2002.122498","article-title":"Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke","volume":"140","author":"Scothorn DJ","year":"2002","unstructured":"Scothorn DJ, Price C, Schwartz D, et al.. Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr. 2002, 140:348-54. 10.1067\/mpd.2002.122498","journal-title":"J Pediatr"},{"key":"ref47","article-title":"Sickle Cell Disease: Basic Principles and Clinical Practice","author":"Hebbel RP","year":"1994","unstructured":"Hebbel RP. Sickle Cell Disease: Basic Principles and Clinical Practice. Raven Press, New York, NY; 1994."},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16063","article-title":"Hydroxycarbamide treatment in children with Sickle Cell Anaemia is associated with more intact white matter integrity: a quantitative MRI study","volume":"187","author":"Kapustin D","year":"2019","unstructured":"Kapustin D, Leung J, Odame I, Williams S, Shroff M, Kassner A. Hydroxycarbamide treatment in children with Sickle Cell Anaemia is associated with more intact white matter integrity: a quantitative MRI study. Br J Haematol. 2019, 187:238-45. 10.1111\/bjh.16063","journal-title":"Br J Haematol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.209.135","article-title":"Neurological soft signs as the stroke risk in sickle cell disease","volume":"209","author":"Melek I","year":"2006","unstructured":"Melek I, Akgul F, Duman T, Yalcin F, Gali E. Neurological soft signs as the stroke risk in sickle cell disease. Tohoku J Exp Med. 2006, 209:135-40. 10.1620\/tjem.209.135","journal-title":"Tohoku J Exp Med"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3536(98)80075-9","article-title":"7 Sickle cell disease: clinical management","volume":"11","author":"Ballas SK","year":"1998","unstructured":"Ballas SK. 7 Sickle cell disease: clinical management. Baillieres Clin Haematol. 1998, 11:185-214. 10.1016\/S0950-3536(98)80075-9","journal-title":"Baillieres Clin Haematol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.hemonc.2019.12.007","article-title":"Standard management of sickle cell disease complications","volume":"13","author":"Abboud MR","year":"2020","unstructured":"Abboud MR. Standard management of sickle cell disease complications. Hematol Oncol Stem Cell Ther. 2020, 13:85-90. 10.1016\/j.hemonc.2019.12.007","journal-title":"Hematol Oncol Stem Cell Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/132201-pediatric-sickle-cell-disease-and-stroke-a-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:13Z","timestamp":1707508093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/132201-pediatric-sickle-cell-disease-and-stroke-a-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,20]]},"references-count":51,"URL":"https:\/\/doi.org\/10.7759\/cureus.34003","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,20]]}}}